Go to content
UR Home

First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation

URN to cite this document:
DOI to cite this document:
Soeder, Yorick ; Loss, Martin ; Johnson, Christian L. ; Hutchinson, James A. ; Haarer, Jan ; Ahrens, Norbert ; Offner, Robert ; Deans, Robert J. ; Van Bokkelen, Gil ; Geissler, Edward K. ; Schlitt, Hans J. ; Dahlke, Marc H.
PDF - Published Version
Date of publication of this fulltext: 21 Dec 2021 06:32


Mesenchymal stem cells and multipotent adult progenitor cells (MAPCs) have been proposed as novel therapeutics for solid organ transplant recipients with the aim of reducing exposure to pharmacological immunosuppression and its side effects. In the present study, we describe the clinical course of the first patient of the phase I, dose-escalation safety and feasibility study, MiSOT-I (Mesenchymal ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons